Goldman Sachs Group Inc Pacific Biosciences Of California, Inc. Transaction History
Goldman Sachs Group Inc
- $613 Billion
- Q4 2024
A detailed history of Goldman Sachs Group Inc transactions in Pacific Biosciences Of California, Inc. stock. As of the latest transaction made, Goldman Sachs Group Inc holds 4,792,776 shares of PACB stock, worth $6.66 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
4,792,776
Previous 4,238,267
13.08%
Holding current value
$6.66 Million
Previous $7.21 Million
21.72%
% of portfolio
0.0%
Previous 0.0%
Shares
20 transactions
Others Institutions Holding PACB
# of Institutions
259Shares Held
256MCall Options Held
3.05MPut Options Held
1.71M-
Cathie Wood Ark Investment Management LLC | St. Petersburg, Fl36MShares$50.1 Million0.58% of portfolio
-
Black Rock Inc. New York, NY23.6MShares$32.8 Million0.0% of portfolio
-
Madrone Advisors, LLC Menlo Park, CA23.4MShares$32.5 Million8.16% of portfolio
-
Edmond De Rothschild Holding S.A. Chambesy, V821.3MShares$29.7 Million0.68% of portfolio
-
Softbank Group Corp Minato Ku Tokyo, M020.5MShares$28.4 Million0.17% of portfolio
About PACIFIC BIOSCIENCES OF CALIFORNIA, INC.
- Ticker PACB
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 224,840,992
- Market Cap $313M
- Description
- Pacific Biosciences of California, Inc. designs, develops, and manufactures sequencing systems to resolve genetically complex problems. The company provides PacBio's Systems, which conduct, monitor, and analyse biochemical sequencing reactions; consumable products, including single molecule real-time (SMRT) cells; and various reagent kits design...